FDA approves new antibiotic for skin infections - New York News

FDA approves new antibiotic for skin infections

Posted: Updated:
(http://www.fda.gov) (http://www.fda.gov)

WASHINGTON (AP) - The Food and Drug Administration has approved a new antibiotic from Durata Therapeutics to treat adults with common skin infections often acquired in U.S. hospitals.

Regulators approved the intravenous drug Dalvance to treat bacterial skin infections caused by common bacteria, including antibiotic-resistant strains of those germs.

The FDA gave Dalvance an expedited review, under a 2012 law designed to encourage research and development of new antibiotics. Under the measure, Chicago-based Durata will receive an additional five years of exclusive marketing rights on the drug.

The FDA said it approved Dalvance based on two trials of nearly 1,300 patients with skin and skin structure infections.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Follow Us!

Share Your Photos & Video

Powered by WorldNow
Didn't find what you were looking for?
All content © Copyright 2000 - 2014 Fox Television Stations, Inc. and Worldnow. All Rights Reserved.
Privacy Policy | Terms of Service | Ad Choices